论文部分内容阅读
目的:观察放射治疗联合介入化疗治疗宫颈癌的疗效及影响预后的相关因素。方法:55例宫颈癌患者放疗并用PF方案动脉灌注新辅助化疗。放疗方法采用规范、全量根治性治疗:体外照射加腔内后装治疗。结果:4年总的生存率为56.4%(31/55),其中Ⅱ期69.6%(16/23),Ⅲ期53.8%(14/26),Ⅳ期16.7%(1/6)。Ⅱ、Ⅲ期中肿瘤直径≤4 cm患者的4年生存率与>4 cm患者的4年生存率比较,差异有统计学意义(P<0.05)。结论:子宫颈癌的预后与临床期别、肿瘤直径大小、病理类型及病理分级有关,放疗联合介入治疗子宫颈癌近期效果较好。
Objective: To observe the radiotherapy combined with interventional chemotherapy in the treatment of cervical cancer and prognosis related factors. Methods: 55 cases of cervical cancer patients radiotherapy and PF regimen arterial infusion of neoadjuvant chemotherapy. Radiotherapy methods using the norms, the full amount of radical treatment: external irradiation plus intracavitary after treatment. Results: The 4-year overall survival rate was 56.4% (31/55), of which 69.6% (16/23) were in stage II, 53.8% (14/26) in stage III, and 16.7% (1/6) in stage IV. The 4-year survival rates of patients with tumor diameter ≤ 4 cm in stage Ⅱ and stage Ⅲ were significantly different from those of patients with> 4 cm in 4-year survival (P <0.05). Conclusion: The prognosis of cervical cancer is related to clinical stage, tumor diameter, pathological type and pathological grade. Radiotherapy combined with interventional therapy for cervical cancer has good effect in recent years.